---
figid: PMC5602294__kccy-16-18-1360633-g001
figlink: /pmc/articles/PMC5602294/figure/f0001/
number: Figure 1
caption: 'Biosynthetic pathway of NAD+ production starting from Na. Nicotinic acid
  (Na) is converted to NAD+ through the 3-step Preiss-Handler pathway. NAPRT catalyzes
  the formation of nicotinic acid mononucleotide (NaMN) by adding a 5-phosphoribose
  group (P-ribose) from 5-phosphoribosyl-1-pyrophosphate to Na. NaMN is converted
  to nicotinic acid adenine dinucleotide (NaAD+) by nicotinamide mononucleotide adenylyltransferase
  1/3 (NMNAT1–3). Finally, NAD+ synthase 1 (NADSYN1) converts NaAD+ to NAD+. The NAPRT
  gene is amplified and overexpressed in a subset of tumors, including ovarian, breast,
  pancreatic and prostate cancer. NAPRT-derived NAD+ supports the activity of DNA
  repair enzymes, such as PARP1/2, which, in turn, may be especially important in
  cancer cells with defective homologous recombination DNA repair to avoid catastrophic
  DNA damage. In addition, NAPRT-mediated NAD+ production turns out to be especially
  important for replenishing the mitochondrial NAD+ stores, for promoting OXPHOS,
  ATP synthesis, and protein synthesis and, ultimately, for regulating cell size.
  PAR: poly (ADP-ribose).'
pmcid: PMC5602294
papertitle: 'Nicotinic acid: A case for a vitamin that moonlights for cancer?.'
reftext: Francesco Piacente, et al. Cell Cycle. 2017;16(18):1635-1636.
pmc_ranked_result_index: '6593'
pathway_score: 0.9510155
filename: kccy-16-18-1360633-g001.jpg
figtitle: Biosynthetic pathway of NAD+ production starting from Na
year: '2017'
organisms: Homo sapiens
ndex: 6ccb0dc7-def2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5602294__kccy-16-18-1360633-g001.html
  '@type': Dataset
  description: 'Biosynthetic pathway of NAD+ production starting from Na. Nicotinic
    acid (Na) is converted to NAD+ through the 3-step Preiss-Handler pathway. NAPRT
    catalyzes the formation of nicotinic acid mononucleotide (NaMN) by adding a 5-phosphoribose
    group (P-ribose) from 5-phosphoribosyl-1-pyrophosphate to Na. NaMN is converted
    to nicotinic acid adenine dinucleotide (NaAD+) by nicotinamide mononucleotide
    adenylyltransferase 1/3 (NMNAT1–3). Finally, NAD+ synthase 1 (NADSYN1) converts
    NaAD+ to NAD+. The NAPRT gene is amplified and overexpressed in a subset of tumors,
    including ovarian, breast, pancreatic and prostate cancer. NAPRT-derived NAD+
    supports the activity of DNA repair enzymes, such as PARP1/2, which, in turn,
    may be especially important in cancer cells with defective homologous recombination
    DNA repair to avoid catastrophic DNA damage. In addition, NAPRT-mediated NAD+
    production turns out to be especially important for replenishing the mitochondrial
    NAD+ stores, for promoting OXPHOS, ATP synthesis, and protein synthesis and, ultimately,
    for regulating cell size. PAR: poly (ADP-ribose).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PARP15
  - PARP4
  - PARP9
  - PARP1
  - PARP3
  - PARP10
  - TNKS
  - TIPARP
  - PARP2
  - PARP14
  - JTB
  - TNKS2
  - PARP12
  - PARP8
  - PARP16
  - NADSYN1
  - NAPRT
  - NMNAT1
  - NMNAT3
  - PARP6
  - PARP11
  - ADP-ribose
  - P-ribose
genes:
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: PAR
  symbol: PAR
  source: hgnc_alias_symbol
  hgnc_symbol: JTB
  entrez: '10899'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: NADSYN1
  symbol: NADSYN1
  source: hgnc_symbol
  hgnc_symbol: NADSYN1
  entrez: '55191'
- word: NAPRT
  symbol: NAPRT
  source: hgnc_symbol
  hgnc_symbol: NAPRT
  entrez: '93100'
- word: NMNAT1/3
  symbol: NMNAT1
  source: hgnc_symbol
  hgnc_symbol: NMNAT1
  entrez: '64802'
- word: NMNAT1/3
  symbol: NMNAT3
  source: hgnc_symbol
  hgnc_symbol: NMNAT3
  entrez: '349565'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
chemicals:
- word: ADP-ribose
  source: MESH
  identifier: D000246
- word: P-ribose
  source: MESH
  identifier: D012266
diseases: []
---
